FDA, Mifepristone NDA Holder Ask 5th Circuit To Stay Court Order Pending Appeals
NEW ORLEANS — The Food and Drug Administration and the company that makes the brand-name mifepristone abortion pill on April 10 filed emergency motions asking the Fifth Circuit U.S. Court of...To view the full article, register now.
Already a subscriber? Click here to view full article